News
The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...
A new study finds a link between the use of antidiabetic drugs like SGLT2 inhibitors and a reduced risk for atrial ...
7h
Health on MSNOzempic Users May Face Higher Risk of a Serious Eye DiseaseA new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...
Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.
1d
bpHope.com on MSNGLP-1s: Real Stories From People With Bipolar DisorderGLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...
Science Natural Supplements Berberine Sets New Standard for Weight Loss, Blood Sugar, and Gut Health Support NEW YORK CITY, ...
23h
Just Food on MSNGLP-1 drugs “alter taste perception” of users, US study claimsGLP-1 drugs “alter taste perception” and "disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a ...
CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...
11h
MedPage Today on MSNLess Real-World GLP-1 Weight Loss; TROA Support; Rebuttal to Vitamin D GuidelinesResearchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...
GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results